Your browser doesn't support javascript.
loading
Prevention of CMV/EBV reactivation by double-specific T cells in patients after allogeneic stem cell transplantation: results from the randomized phase I/IIa MULTIVIR-01 study.
Gerbitz, Armin; Gary, Regina; Aigner, Michael; Moosmann, Andreas; Kremer, Anita; Schmid, Christoph; Hirschbuehl, Klaus; Wagner, Eva; Hauptrock, Beate; Teschner, Daniel; Roesler, Wolf; Spriewald, Bernd; Tischer, Johanna; Moi, Stephanie; Balzer, Heidi; Schaffer, Stefanie; Bausenwein, Judith; Wagner, Anja; Schmidt, Franziska; Brestrich, Jens; Ullrich, Barbara; Maas, Stefanie; Herold, Susanne; Strobel, Julian; Zimmermann, Robert; Weisbach, Volker; Hansmann, Leo; Lammoglia-Cobo, Fernanda; Remberger, Mats; Stelljes, Matthias; Ayuk, Francis; Zeiser, Robert; Mackensen, Andreas.
Afiliação
  • Gerbitz A; Department of Medicine 5 Hematology/Oncology, University Hospital Erlangen, Erlangen, Germany.
  • Gary R; Princess Margaret Cancer Centre, Division of Medical Oncology/Hematology, Toronto, ON, Canada.
  • Aigner M; Department of Medicine 5 Hematology/Oncology, University Hospital Erlangen, Erlangen, Germany.
  • Moosmann A; Department of Medicine 5 Hematology/Oncology, University Hospital Erlangen, Erlangen, Germany.
  • Kremer A; Department of Medicine 3, LMU University Hospital, Munich, Germany.
  • Schmid C; Helmholtz Center Munich, Institute of Virology, Munich, Germany.
  • Hirschbuehl K; Deutsches Zentrum für Infektionsforschung (DZIF) - German Center for Infection Research, Munich, Germany.
  • Wagner E; Department of Medicine 5 Hematology/Oncology, University Hospital Erlangen, Erlangen, Germany.
  • Hauptrock B; Department of Medicine 2, University Hospital Augsburg, Augsburg, Germany.
  • Teschner D; Department of Medicine 2, University Hospital Augsburg, Augsburg, Germany.
  • Roesler W; Department of Medicine 3, University Hospital Mainz, Mainz, Germany.
  • Spriewald B; Department of Medicine 3, University Hospital Mainz, Mainz, Germany.
  • Tischer J; Department of Medicine 3, University Hospital Mainz, Mainz, Germany.
  • Moi S; Department of Medicine 5 Hematology/Oncology, University Hospital Erlangen, Erlangen, Germany.
  • Balzer H; Department of Medicine 5 Hematology/Oncology, University Hospital Erlangen, Erlangen, Germany.
  • Schaffer S; Department of Medicine 3, LMU University Hospital, Munich, Germany.
  • Bausenwein J; Department of Medicine 5 Hematology/Oncology, University Hospital Erlangen, Erlangen, Germany.
  • Wagner A; Department of Medicine 5 Hematology/Oncology, University Hospital Erlangen, Erlangen, Germany.
  • Schmidt F; Department of Medicine 5 Hematology/Oncology, University Hospital Erlangen, Erlangen, Germany.
  • Brestrich J; Department of Medicine 5 Hematology/Oncology, University Hospital Erlangen, Erlangen, Germany.
  • Ullrich B; Department of Medicine 5 Hematology/Oncology, University Hospital Erlangen, Erlangen, Germany.
  • Maas S; Department of Medicine 5 Hematology/Oncology, University Hospital Erlangen, Erlangen, Germany.
  • Herold S; Department of Hematology, Oncology and Tumor Immunology, Charite University Hospital Berlin, Berlin, Germany.
  • Strobel J; Medical Center for Information and Communication Technology, University Hospital Erlangen, Erlangen, Germany.
  • Zimmermann R; Center for Clinical Studies (CCS), University Hospital Erlangen, Erlangen, Germany.
  • Weisbach V; Center for Clinical Studies (CCS), University Hospital Erlangen, Erlangen, Germany.
  • Hansmann L; Department of Transfusion Medicine, University Hospital Erlangen, Erlangen, Germany.
  • Lammoglia-Cobo F; Department of Transfusion Medicine, University Hospital Erlangen, Erlangen, Germany.
  • Remberger M; Department of Transfusion Medicine, University Hospital Erlangen, Erlangen, Germany.
  • Stelljes M; Department of Hematology, Oncology and Tumor Immunology, Charite University Hospital Berlin, Berlin, Germany.
  • Ayuk F; Department of Hematology, Oncology and Tumor Immunology, Charite University Hospital Berlin, Berlin, Germany.
  • Zeiser R; Department of Medical Sciences, Uppsala University and Clinical Research and Development Unit (KFUE), Uppsala University Hospital, Uppsala, Sweden.
  • Mackensen A; Department of Hematology/Oncology, University Hospital Muenster, Muenster, Germany.
Front Immunol ; 14: 1251593, 2023.
Article em En | MEDLINE | ID: mdl-37965339
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Citomegalovirus / Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Citomegalovirus / Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article